UNSPSC 51451807: Albendazole sulfoxide

This classification denotes an antihelminthic agent with the molecular formula C12H15N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J39B52TV34, chemically known as methyl (5-(propylsulfinyl)-1h-benzo(d)imidazol-2-yl)carbamate, but more generally known as albendazole sulfoxide, which bears US NIH Compound Identifier 83969. European Medicines Agency schedules albendazole sulfoxide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05295MIG.

Most nations, for tariff purposes, schedule albendazole sulfoxide under HS 29339990. SMILES: CCC[S+](C1CCC2C(C1)NC([NH]2)NC(=O)OC)[O-].

UNSPSC 51451807 Albendazole sulfoxide is a Commodity code that in recent state and local solicitations appears to tag pharmaceutical procurement opportunities that do not align with the code's nominal scope. The recent opportunities posted under this code include a Seminole County, Florida naloxone and drug deactivation systems purchase, a Texas Health and Human Services Commission direct-to-manufacturer prescriptions request for information, a Tampa Fire Department medical and first aid supplies procurement, and a Minnesota multistate cooperative purchasing alliance contract for generic pharmaceuticals and over-the-counter products. None of these solicitations explicitly reference albendazole sulfoxide or antiparasitic pharmaceuticals; the code appears to be a mislabeling artifact in state and local procurement systems rather than a reliable signal of anthelmintic drug procurement activity.

The recent opportunities under this code span multiple issuing-body types—county health departments, state health agencies, municipal fire departments, and multistate cooperative purchasing alliances—with geographic activity in Florida, Texas, Minnesota, and Oregon. The most recent solicitation is Seminole County's IFB 60459723LAS for naloxone and drug deactivation systems with a due date of July 26, 2023 (materially dated relative to the posting of June 30, 2026); the City of Tampa's invitation to bid 26-P-00145 for medical and first aid supplies with an estimated contract value of $700,000 and response date of March 13, 2026; and the Minnesota MMCAP RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products due March 26, 2026. Because the code's recent activity does not reflect actual albendazole sulfoxide procurement, the code shows little relevant recent activity and does not serve as a reliable filtering mechanism for anthelmintic pharmaceutical opportunities in state and local government markets.